Results 291 to 300 of about 143,284 (315)

The Role of Inflammation-Associated Factors in Head and Neck Squamous Cell Carcinoma

Journal of Inflammation Research, 2023
Peng Zhang
exaly  

Pathology of squamous cell carcinomas of the head and neck

Current Opinion in Oncology, 1990
openaire   +2 more sources

Squamous cell carcinoma of the head and neck: past progress and future promise

Ca-A Cancer Journal for Clinicians, 1998
Helmuth Goepfert
exaly  

Oral cavity and oropharyngeal squamous cell carcinoma—an update

Ca-A Cancer Journal for Clinicians, 2015
Angela C Chi, Brad W Neville
exaly  

Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer

Ca-A Cancer Journal for Clinicians, 2008
Everett E Vokes
exaly  

Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
William M Lydiatt, Snehal G Patel, Margaret S Brandwein   +2 more
exaly  

American Cancer Society Head and Neck Cancer Survivorship Care Guideline

Ca-A Cancer Journal for Clinicians, 2016
Ezra E W Cohen, Nader Sadeghi, Katherine A Hutcheson   +2 more
exaly  

Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck

Annals of Oncology, 2012
R Hitt, A Irigoyen, H Cortes-Funes
exaly  

Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)

Annals of Oncology, 2018
Jean-Pascal Machiels, Paolo Bossi, Jessica Menis   +2 more
exaly  

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Lancet, The, 2019
Ezra Cohen, Jonathan Cheng, Mirelis Acosta-Rivera   +2 more
exaly